Skip to main content

Table 2 Univariate and multivariate COX regression analyses for metastatic gallbladder adenocarcinoma patients

From: Site-specific metastases of gallbladder adenocarcinoma and their prognostic value for survival: a SEER-based study

Features

Overall survival

Cancer specific survival

Univariate

Multivariate

Univariate

Multivariate

HR (95% CI)

P-value

HR (95% CI)

P-value

HR (95% CI)

P-value

HR (95% CI)

P-value

Age

 < 60

1.000 (Reference)

 

1.000 (Reference)

 

1.000 (Reference)

 

1.000 (Reference)

 

 60–69

1.045 (0.900–1.212)

0.566

1.029 (0.885–1.195)

0.711

1.023 (0.880–1.190)

0.764

1.012 (0.869–1.178)

0.879

 70–79

1.243 (1.070–1.444)

0.004

1.042 (0.894–1.215)

0.599

1.221 (1.049–1.421)

0.010

1.027 (0.879–1.200)

0.736

 ≥ 80

1.774 (1.499–2.100)

< 0.001

1.167 (0.975–1.396)

0.092

1.758 (1.482–2.085)

0.000

1.156 (0.964–1.387)

0.117

Gender

 Male

1.000 (Reference)

 

1.000 (Reference)

 

1.000 (Reference)

   

 Female

0.878 (0.779–0.988)

0.031

0.914 (0.809–1.033)

0.151

0.897 (0.794–1.012)

0.077

  

Marriage

 Married

1.000 (Reference)

 

1.000 (Reference)

 

1.000 (Reference)

 

1.000 (Reference)

 

 Unmarried

1.204 (1.076–1.346)

0.001

1.026 (0.910–1.155)

0.679

1.206 (1.0761.352)

0.001

1.012 (0.898–1.140)

0.844

 Unknown

1.166 (0.870–1.563)

0.304

0.874 (0.647–1.180)

0.380

1.180 (0.878–1.587)

0.273

0.880 (0.650–1.192)

0.411

Race

 White

1.000 (Reference)

   

1.000 (Reference)

   

 Black

1.033 (0.883–1.209)

0.683

  

1.031 (0.879–1.208)

0.711

  

 Others

1.050 (0.879–1.254)

0.589

  

1.043 (0.871–1.250)

0.645

  

Grade

 I

1.000 (Reference)

 

1.000 (Reference)

 

1.000 (Reference)

 

1.000 (Reference)

 

 II

1.087 (0.770–1.535)

0.636

1.173 (0.828–1.662)

0.368

1.046 (0.740–1.478)

0.800

1.119 (0.789–1.587)

0.527

 III + IV

1.643 (1.174–2.298)

0.004

1.704 (1.212–2.397)

0.002

1.582 (1.130–2.214)

0.008

1.639 (1.165–2.307)

0.005

 Unknown

1.893 (1.364–2.627)

< 0.001

1.489 (1.046–2.120)

0.027

1.845 (1.329–2.560)

< 0.001

1.455 (1.021–2.073)

0.038

T stage

 T0

1.000 (Reference)

 

1.000 (Reference)

 

1.000 (Reference)

 

1.000 (Reference)

 

 T1

1.048 (0.644–1.704)

0.851

1.349 (0.823–2.211)

0.235

1.009 (0.620–1.643)

0.971

1.273 (0.776–2.088)

0.339

 T2

0.590 (0.365–0.952)

0.031

1.027 (0.621–1.699)

0.917

0.568 (0.351–0.918)

0.021

0.982 (0.593–1.626)

0.943

 T3

0.877 (0.555–1.386)

0.574

1.082 (0.678–1.725)

0.741

0.849 (0.537–1.341)

0.483

1.034 (0.648–1.649)

0.889

 T4

0.869 (0.528–1.431)

0.581

0.948 (0.573–1.568)

0.835

0.858 (0.521–1.414)

0.548

0.926 (0.560–1.532)

0.764

 TX

1.087 (0.685–1.725)

0.725

1.077 (0.677–1.714)

0.755

1.048 (0.660–1.664)

0.843

1.027 (0.645–1.635)

0.911

N stage

 N0

1.000 (Reference)

   

1.000 (Reference)

   

 N1

0.937 (0.820–1.070)

0.336

  

0.938 (0.819–1.074)

0.352

  

 N2

0.985 (0.827–1.173)

0.863

  

1.005 (0.842–1.198)

0.958

  

 NX

1.359 (1.156–1.597)

< 0.001

  

1.352 (1.147–1.594)

< 0.001

  

Surgery at primary site

 Yes

1.000 (Reference)

 

1.000 (Reference)

 

1.000 (Reference)

 

1.000 (Reference)

 

 No

1.633 (1.452–1.836)

< 0.001

1.578 (1.329–1.873)

< 0.001

1.641 (1.456–1.849)

< 0.001

1.588 (1.334–1.890)

< 0.001

Radiation

 Yes

1.000 (Reference)

 

1.000 (Reference)

 

1.000 (Reference)

 

1.000 (Reference)

 

 No

1.482 (1.188–1.849)

< 0.001

1.125 (0.8981.409)

0.307

1.454 (1.163–1.817)

0.001

1.107 (0.882–1.388)

0.380

Chemotherapy

 Yes

1.000 (Reference)

 

1.000 (Reference)

 

1.000 (Reference)

 

1.000 (Reference)

 

 No

2.554 (2.282–2.858)

< 0.001

2.711 (2.3973.066)

< 0.001

2.556 (2.280–2.865)

< 0.001

2.723 (2.404–3.086)

< 0.001

Metastatic type

 Single site

1.000 (Reference)

   

1.000 (Reference)

   

 Multiple sites

1.001 (0.894–1.120)

0.990

 

0.933

0.995 (0.888–1.116)

0.933

  

Tumor size

 < 3 cm

1.000 (Reference)

 

1.000 (Reference)

 

1.000 (Reference)

 

1.000 (Reference)

 

 < 5 cm

1.373 (1.109–1.700)

0.004

1.340 (1.076–1.668)

0.009

1.372 (1.106–1.703)

0.004

1.330 (1.066–1.659)

0.012

 ≥ 5 cm

1.420 (1.164–1.731)

0.001

1.354 (1.101–1.666)

0.004

1.391 (1.138–1.701)

0.001

1.327 (1.076–1.636)

0.008

 Unknown

1.657 (1.399–1.961)

< 0.001

1.387 (1.158–1.661)

< 0.001

1.630 (1.374–1.933)

< 0.001

1.356 (1.130–1.627)

0.001

  1. Other races include Asian or Pacific Islander and American Indian/Alaska Native; Grade I = well differentiated, II = moderately differentiated, III = poorly differentiated, IV = undifferentiated; HR = hazard ratio; CI = confidence interval